Literature DB >> 24780644

Nuclear translocation of heparan sulfate proteoglycans and their functional significance.

Ilona Kovalszky1, Anders Hjerpe2, Katalin Dobra3.   

Abstract

BACKGROUND: Heparan sulfate proteoglycans (HSPGs) are important constituents of the cell membrane and they act as co-receptors for cellular signaling. Syndecan-1, glypican and perlecan also translocate to the nucleus in a regulated manner. Similar nuclear transport of growth factors and heparanase indicate a possible co-regulation and functional significance. SCOPE OF REVIEW: In this review we dissect the structural requirement for the nuclear translocation of HSPGs and their functional implications.s MAJOR
CONCLUSIONS: The functions of the nuclear HSPGs are still incompletely understood. Evidence point to possible functions in hampering cell proliferation, inhibition of DNA topoisomerase I activity and inhibition of gene transcription. GENERAL SIGNIFICANCE: HSPGs influence the behavior of malignant tumors in many different ways. Modulating their functions may offer powerful tools to control fundamental biological processes and provide the basis for subsequent targeted therapies in cancer. This article is part of a Special Issue entitled Matrix-mediated cell behaviour and properties.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gene transcription; Heparan sulfate; Nuclear translocation; Proliferation; Proteoglycan

Mesh:

Substances:

Year:  2014        PMID: 24780644     DOI: 10.1016/j.bbagen.2014.04.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Fell-Muir Lecture: Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour.

Authors:  John R Couchman; Sandeep Gopal; Hooi Ching Lim; Steffen Nørgaard; Hinke A B Multhaupt
Journal:  Int J Exp Pathol       Date:  2014-12-26       Impact factor: 1.925

Review 2.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

3.  2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.

Authors:  Shuo Zheng; Apparao B Kummarapurugu; Daniel K Afosah; Nehru Viji Sankaranarayanan; Rio S Boothello; Umesh R Desai; Thomas Kennedy; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

Review 4.  Proteolysis: a key post-translational modification regulating proteoglycans.

Authors:  Timothy J Mead; Sumit Bhutada; Daniel R Martin; Suneel S Apte
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

Review 5.  What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype.

Authors:  Anthony J Hayes; James Melrose
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 6.  Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.

Authors:  Israel Vlodavsky; Uri Barash; Hien M Nguyen; Shi-Ming Yang; Neta Ilan
Journal:  Semin Thromb Hemost       Date:  2021-04-01       Impact factor: 6.398

7.  Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease.

Authors:  Cem Çekiç; Adnan Kırcı; Sezgin Vatansever; Fatih Aslan; Huriye Erbak Yılmaz; Emrah Alper; Mahmut Arabul; Elif Sarıtaş Yüksel; Belkıs Ünsal
Journal:  Gastroenterol Res Pract       Date:  2015-07-29       Impact factor: 2.260

Review 8.  Extracellular matrix as target for antitumor therapy.

Authors:  Revekka Harisi; Andras Jeney
Journal:  Onco Targets Ther       Date:  2015-06-09       Impact factor: 4.147

9.  Distribution of syndecan-1 protein in developing mouse teeth.

Authors:  Anna Filatova; Pierfrancesco Pagella; Thimios A Mitsiadis
Journal:  Front Physiol       Date:  2015-01-15       Impact factor: 4.566

10.  Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.

Authors:  József Dudás; József Bocsi; Alexandra Fullár; Kornélia Baghy; Tibor Füle; Saule Kudaibergenova; Ilona Kovalszky
Journal:  Biomed Res Int       Date:  2014-09-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.